For sponsorship opportunities, please contact:
ISICEM Manager Véronique De Vlaeminck
We thank the following companies for sponsoring the e-ISICEM 2020.
Amomed/AOP Orphan Group
As part of the AOP Orphan Group AMOMED provides specialty intensive care medication for critically ill patients, thereby the company focuses on cardiovascular treatment. From its headquarters in Vienna, the AOP Orphan Group leads more than 20 subsidiaries and representative offices across the whole of Europe as well as in the United Arab Emirates and Israel.
E-Satellite Meeting(s)Wednesday September 16 (13:30- 14:15 CET)
Baxter International Inc.
Every day, millions of patients and caregivers rely on Baxter’s leading portfolio of critical care, nutrition, renal, hospital and surgical products. For more than 85 years, we’ve been operating at the critical intersection where innovations that save and sustain lives meet the healthcare providers that make it happen. With products, technologies and therapies available in more than 100 countries, Baxter’s employees worldwide are now building upon the company’s rich heritage of medical breakthroughs to advance the next generation of transformative healthcare innovations.
E-Satellite Meeting(s)Tuesday September 15 (17:00- 17:45 CET) Wednesday September 16 (12:30- 13:15 CET)
CytoSorbents Europe GmbH
The CytoSorb therapy is based on an extracorporeal blood purification procedure that can effectively reduce excessive levels of inflammatory mediators. This is intended to alleviate the excess systemic inflammatory response, the cytokine storm, associated with systemic hyperinflammation or septic shock. Thus, the life-threatening complications of a cytokine storm can be avoided, and, above all, the stabilization of hemodynamics promoted.
E-Satellite Meeting(s)Wednesday September 16 (16:15- 17:00 CET)
In this one-day virtual symposium, leading experts in the field will cover all aspects of hemodynamic monitoring in critically ill patients, including basic physiological concepts; interpretation of specific variables such as cardiac output, blood lactate and venous oxygenation; optimal monitoring in conditions such as ARDS and sepsis; and use of monitoring to guide therapeutic interventions, such as fluid administration, vasopressor therapy and ECMO.
At the conclusion of this activity, the participant will be better able to:
- understand the rationale for monitoring the different hemodynamic variables in critically ill patients
- select the best monitoring method(s) in specific patient groups or for particular goals and discuss their advantages and limitations
- appreciate how to integrate multiple variables to optimally monitor a patient’s hemodynamic status
- interpret and apply the data obtained to ensure appropriate management of individual patients
E-Satellite Meeting(s)Wednesday September 16 (11:45- 12:30 CET)
Fresenius Medical Care
Fresenius Medical Care is a leading healthcare company with special focus on renal care. Besides a wide range of products for the treatment of acute kidney injury (AKI), the company also offers specialized extracorporeal blood treatment therapies for various critical diseases, including heart and lung failure, sepsis and severe metabolic disorders.
E-Satellite Meeting(s)Tuesday September 15 (12:30- 13:15 CET)
GE Healthcare is a leading global medical technology and digital solutions innovator. GE Healthcare enables clinicians to make faster, more informed decisions through intelligent devices, diagnostic pharmaceuticals, data analytics, applications and services, supported by its Edison intelligence platform. With over 100 years of healthcare industry experience and around 50,000 employees globally, the company operates at the center of an ecosystem working toward precision health, digitizing healthcare, helping drive productivity and improve outcomes for patients, providers, health systems and researchers around the world.
E-Satellite Meeting(s)Thursday September 17 (16:15- 17:00 CET)
Aerogen is the global leader in the design and manufacture of high-performance aerosol drug delivery systems. Aerogen’s vibrating mesh technology turns liquid medication into a fine particle mist, gently and effectively delivering drugs to your patient’s lungs. Aerogen’s innovative products, such as the Solo and Ultra, significantly improve aerosol drug delivery resulting in better patient care throughout the hospital.
E-Satellite Meeting(s)Tuesday September 15 (11:00- 11:45 CET)
Aspen is a global pharmaceutical company with a proud South African heritage dating back more than 160 years. The Group has a business presence in approximatively 60 countries and more than 10,000 employees worldwide with an extensive portfolio in thrombosis, anesthesia, high potency & cytotoxics. Through strategic multinational partnerships, Aspen has established its leadership in critical care offering a comprehensive portfolio of credible, high-quality solutions manufactured in Europe.
E-Satellite Meeting(s)Thursday September 17 (13:30- 14:15 CET)
World leader in microbiology, specialized in immunoassays and leading pioneer in syndromic molecular testing, bioMérieux provides diagnostic solutions (systems, reagents, software, services) to answer major public health issues, such as antibiotic resistance, sepsis and respiratory infections including COVID-19 as well as critical illnesses like acute kidney injury. bioMérieux operates in 44 countries and serves over 160 countries through its distributors.
E-Satellite Meeting(s)Thursday September 17 (15:00- 15:30 CET) Thursday September 17 (18:30- 19:10 CET)
Biotest is a provider of plasma proteins and biological drugs. Biotest has specialized primarily in the areas of clinical immunology, hematology and intensive care medicine. Biotest develops and markets immunoglobulins, coagulation factors and albumin based on human blood plasma. These are used for diseases of the immune and hematopoietic systems.
ContactFabian Freiberg mail
E-Satellite Meeting(s)Thursday September 17 (11:00- 11:45 CET)
CSL Behring is a global biotherapeutics leader driven by our promise to save lives. We meet patients’ needs using the latest technologies to develop and deliver innovative biotherapies that are used to treat serious and rare conditions such as coagulation disorders, primary immune deficiencies, hereditary angioedema and respiratory disease.
E-Satellite Meeting(s)Thursday September 17 (12:30- 13:15 CET)
Exthera Medical Corporation
ExThera Medical presents Seraph® 100 Microbind® Affinity Blood Filter (Seraph 100), a unique blood filter designed to rapidly reduce the concentration of bloodstream pathogens. It is safe and effective against drug susceptible and resistant bacteria along with many viruses, including SARS-CoV-2. Randomized controlled clinical trials are underway in Europe and the US for sepsis and COVID-19.
E-Satellite Meeting(s)Tuesday September 15 (18:30- 19:15 CET)
Fisher & Paykel Healthcare
Fisher & Paykel entered the respiratory care market in 1971 with the development of a unique respiratory humidifier system for use in critical care. We now offer a broad range of products and systems for use in respiratory and acute care and in the treatment of obstructive sleep apnea (OSA).
E-Satellite Meeting(s)Tuesday September 15 (16:15- 17:00 CET) Wednesday September 16 (17:00- 17:45 CET)
Fresenius Kabi is a global healthcare company that specializes in lifesaving medicines and technologies for infusion, transfusion and clinical nutrition. The products and services are used to help care for critically and chronically ill patients. The portfolio comprises intravenous generic drugs, infusion therapies, clinical nutrition, devices, biosimilars as well as products for collection and processing of blood and cell components.
E-Satellite Meeting(s)Thursday September 17 (17:00- 17:45 CET)
Jafron Biomedical Co., LTD
Established in 1989, Jafron engaged in research, production and marketing of medical devices. Its blood purification products provide solutions to sepsis, ESRD, liver failure, etc., and have been adopted in over 60 countries, with about 3 million cases annually. By contributing to global medicare with original created technology, Jafron is practicing the vision of bringing a bright human life.
E-Satellite Meeting(s)Thursday September 17 (15:30- 16:15 CET)
Masimo is a global medical technology company that develops and produces a wide array of industry-leading monitoring and noninvasive technologies, including innovative measurements, sensors, patient monitors, automation and ventilation therapy solutions.
E-Satellite Meeting(s)Wednesday September 16 (18:30- 19:15 CET)
Merck & Co, Inc
For more than 125 years, MSD, trade name of Merck & Co., Inc., with headquarters in Kenilworth, N.Y., USA, has been inventing for life, bringing forward medicines and vaccines for many of the world's most challenging diseases. We demonstrate our commitment to patients and population health by increasing access to health care through far-reaching policies, programs and partnerships. Today, MSD continues to be at the forefront of research to prevent and treat diseases that threaten people and animals — including cancer, infectious diseases such as HIV and Ebola, and emerging animal diseases — as we aspire to be the premier research-intensive biopharmaceutical company in the world.
E-Satellite Meeting(s)Tuesday September 15 (11:45- 12:30 CET)
Nestlé Health Science
Founded in 2011, Nestlé Health Science (NHSc) is a globally recognized leader in the field of nutritional science. We offer an extensive consumer health portfolio of science-based consumer health, medical nutrition and supplement brands, and we are committed to redefining the management of health. We currently produce over a billion nutritional health solutions for consumers, patients and their healthcare providers.
E-Satellite Meeting(s)Wednesday September 16 (11:00- 11:45 CET)
Nutricia Advanced Medical Nutrition
Since 1896, Nutricia has been pioneering nutritional solutions to address some of the world’s biggest health challenges. Providing nutrition for intensive care is a key part of this to ensure survival and optimal recovery. Nutricia is part of Danone, a global leader with a unique health-focused portfolio in food and beverages.
E-Satellite Meeting(s)Tuesday September 15 (15:00- 15:45 CET)
Headquartered in Lachen, Switzerland, Octapharma is one of the largest human protein manufacturers in the world, developing and producing human proteins from human plasma and human cell lines. Octapharma employs more than 10,000 people worldwide to support the treatment of patients in 118 countries with products across three therapeutic areas: hematology, immunotherapy and critical care.
E-Satellite Meeting(s)Tuesday September 15 (13:30- 14:15 CET)
Thermo Fisher Scientific
B·R·A·H·M·S GmbH, part of Thermo Fisher Scientific, investigates, develops and manufactures novel diagnostic testing procedures to improve early diagnosis and treatment of life threatening diseases. With high-quality immunodiagnostic tests for prenatal screening, cardiovascular, pulmonary, and cancer disorders as well as particularly for sepsis, the company contributes to the creation of a healthier future − to the greatest advantage for medical professionals and patients.
E-Satellite Meeting(s)Thursday September 17 (11:45- 12:30 CET)
Maker of brands like AirLife™, Vital Signs™ and Vyntus™, Vyaire Medical brings a laser focus to improving patient outcomes and increasing value for customers. Formed in October 2016, Vyaire serves healthcare customers around the world with innovative device and service solutions across the respiratory and anesthesia continua of care.
E-Satellite Meeting(s)Wednesday September 16 (15:00- 15:45 CET)
This event has been developed following the MedTech Europe Code of Ethical Business Practice.